Estimate Recalculated Jun 12, 2025 08:30PM EST
Kevin Rakin has an estimated net worth of $1.03 Million. This is based on reported shares across multiple companies, which include Omrix Biopharmaceuticals, Inc., GENAISSANCE PHARMACEUTICALS INC, HISTOGENICS CORP, ORAMED PHARMACEUTICALS INC., Quantum-Si Inc, ELUTIA INC., VION PHARMACEUTICALS INC, and CLINICAL DATA INC.
Kevin Rakin's CIK is 0001184421
2021 was Kevin Rakin's most active year for acquiring shares with 7 total transactions. Kevin Rakin's most active month to acquire stocks was the month of November. 2021 was Kevin Rakin's most active year for disposing of shares, totalling 10 transactions. Kevin Rakin's most active month to dispose stocks was the month of July. 2006 saw Kevin Rakin paying a total of $1,298,500.00 for 84,360 shares, this is the most they've acquired in one year. In 2021 Kevin Rakin cashed out on 131,329 shares for a total of $993,131.29, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!